Cue Applies for EUA for Flu + COVID-19 Molecular Test
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Covid 19, Flu & Respiratory Infections, Molecular Diagnostic Analyzers, POC Rapid Assays |
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Emerging & Zoonotic Diseases, Sexually Transmitted Diseases |
With demand for monkeypox testing, labs will need to be aware of the regulations related to coding, reimbursement, and compliance issues.
Read MorePosted by Chris Wolski | Oct 3, 2022 | Covid 19 |
During a televised interview last year, President Joe Biden declared the “pandemic is over,” but is it really, truly “over”?
Read MorePosted by Andy Lundin | Oct 3, 2022 | Covid 19 |
Scientists found that sensor data significantly improved the seven-day average predictions for COVID infection.
Read MorePosted by Andy Lundin | Sep 30, 2022 | Covid 19 |
A team of scientists have developed a simple, rapid, highly sensitive method for the detection of SARS-CoV-2 in wastewater. The method, EPISENS-S, which does not require specialized equipment.
Read More